Hormonal Implants Market Analysis By Key Players, SWOT Analysis, Growth Factors and Forecast till 2028
Market Highlights
The Global Hormonal
Implants Market is estimated to have a positive growth at the CAGR of ~5.0%
during the forecast period of 2019–2025.
A study observed that no pregnancy was observed in a group
of certain women using hormonal implants for five years. Safety from unwanted
pregnancies and suitable government programmers are the major factors driving
the market growth.
However, cases of side-effects related to hormonal
contraceptives, pricing variations, and limited availability of the product are
restraining the growth of the market during the assessment period is hindering
the growth of the global hormonal implants market in the forecast period.
Global, as well as local players, are present in the
hormonal implants market. A majority of the market is currently held by global
players like Allergan. In May 2016, ALLERGAN took an initiative to help the US
military servicewomen to access LILETTA under the Federal Supply Schedule (FSS)
price of USD 55.83 to educate these servicewomen about the importance of
contraception.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/8242
Regional Analysis
The global hormonal implants market, by region, is segmented
into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The
hormonal implants market in the Americas has further been segmented into North
America and Latin America, with the North American market divided into the US
and Canada. The European hormonal implants market has been sub-divided into
Western Europe and Eastern Europe. Western Europe has further been segmented as
Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The
hormonal implants market in Asia-Pacific has been segmented into Japan, China,
India, South Korea, Australia, and the rest of Asia-Pacific. The hormonal
implants market in the Middle East & Africa has been divided into the
Middle East and Africa.
Segmental Analysis
The global hormonal implants market has been segmented based
hormone, type, distribution sector, end user, and region.
The market, based on hormone, has been bifurcated into
levonorgestrel and etonogestrel. The levonorgestrel segment is anticipated to
hold the largest share in the market, market due to the wider preferability and
longer durability compared to other contraceptives for the use of hormonal
implants.
The market, based on the distribution sector, has been
segmented into the public sector and private sector. The public sector market
is expected to hold the largest share in the market, due to increasing adoption
rates in public healthcare facilities under various government regulations.
The market, by end-user, has been divided into hospitals
& clinics, academic & research institutes. The hospitals & clinics
segment is expected to lead the market, due to the major commercialization is
done through them.
Key Players
Some of the key players in the global hormonal implants
market are Shanghai Dahua Pharmaceuticals Co., Merck & Co., Inc., Bayer
HealthCare, Ltd and Allergan.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/hormonal-implants-market-8242
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment